Davide Ghinolfi, Daniele Pezzati, Erion Rreka, Emanuele Balzano, Gabriele Catalano, Laura Coletti, Giovanni Tincani, Paola Carrai, Stefania Petruccelli, Caterina Martinelli, Rebecca Aglietti, Maria Lucia Bindi, Riccardo Morganti, Giandomenico Biancofiore, Paolo De Simone – 5 June 2019
Serena Gasperini, Lorenzo D’Antiga – 5 June 2019
Nicole T. Shen, Akhil Shenoy, Robert S. Brown, Elizabeth C. Verna – 5 June 2019
Antonio Galante, Oyedele Adeyi, Lawrence Lau, Atul Humar, Zita Galvin, Nazia Selzner, Leslie Lilly, Gonzalo Sapisochin, Mamatha Bhat – 4 June 2019
Sho Ibuki, Yuta Abe, Keita Shimata, Yasuko Narita, Tomoaki Irie, Hidekazu Yamamoto, Yasuhiko Sugawara, Taizo Hibi – 4 June 2019
Guruprasad P. Aithal – 3 June 2019
Kouichi Miura, Hironori Yamamoto – 3 June 2019
Helene Gellert‐Kristensen, Børge Grønne Nordestgaard, Anne Tybjærg‐Hansen, Stefan Stender – 3 June 2019 – A common loss‐of‐function variant in HSD17B13 (rs72613567:TA) was recently found to protect from chronic liver disease. Whether the variant confers protection from specific risk factors for liver disease is unclear. We tested the association of rs72613567 with plasma levels of alanine transaminase (ALT) and clinical liver disease and mortality in 111,612 individuals from the Danish general population, including 497 with cirrhosis and 113 with hepatocellular carcinoma.
3 June 2019
Hua Wu, Tian‐Yu Yang, Yi Li, Wen‐Long Ye, Feng Liu, Xiao‐Shun He, Jing‐Ru Wang, Wen‐Juan Gan, Xiu‐Ming Li, Shen Zhang, Yuan‐Yuan Zhao, Jian‐Ming Li – 3 June 2019 – The oncogene c‐Myc is aberrantly expressed and plays a key role in malignant transformation and progression of hepatocellular carcinoma (HCC). Here, we report that c‐Myc is significantly up‐regulated by tumor necrosis factor receptor–associated factor 6 (TRAF6), an E3 ubiquitin ligase, in hepatocarcinogenesis.